Thomas Friedemann

624 total citations
23 papers, 446 citations indexed

About

Thomas Friedemann is a scholar working on Complementary and alternative medicine, Pharmacology and Pharmacology. According to data from OpenAlex, Thomas Friedemann has authored 23 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Complementary and alternative medicine, 8 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Thomas Friedemann's work include Acupuncture Treatment Research Studies (8 papers), Plant-based Medicinal Research (5 papers) and Andrographolide Research and Applications (4 papers). Thomas Friedemann is often cited by papers focused on Acupuncture Treatment Research Studies (8 papers), Plant-based Medicinal Research (5 papers) and Andrographolide Research and Applications (4 papers). Thomas Friedemann collaborates with scholars based in Germany, China and Portugal. Thomas Friedemann's co-authors include Sven Schröder, Gesa Meyer‐Hamme, Henry Johannes Greten, Udo Schumacher, Tao Yi, Alexander Kai‐Man Leung, Thomas Efferth, Christian Gerloff, Matthias Rostock and Giovanna Franconi and has published in prestigious journals such as Journal of Ethnopharmacology, Radiation Research and British Journal of Urology.

In The Last Decade

Thomas Friedemann

22 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Friedemann Germany 13 164 113 105 95 75 23 446
Zhixiu Lin Hong Kong 10 268 1.6× 68 0.6× 96 0.9× 179 1.9× 56 0.7× 16 650
In-Chan Seol South Korea 8 97 0.6× 77 0.7× 87 0.8× 118 1.2× 55 0.7× 72 486
Dong Wan China 15 104 0.6× 56 0.5× 59 0.6× 376 4.0× 75 1.0× 30 728
Chethan Sampath United States 14 69 0.4× 79 0.7× 32 0.3× 153 1.6× 67 0.9× 34 548
Meijuan Li China 14 102 0.6× 83 0.7× 62 0.6× 174 1.8× 50 0.7× 61 598
Zümrüt Doğan Türkiye 15 52 0.3× 68 0.6× 85 0.8× 113 1.2× 133 1.8× 35 576
Kung‐Chang Hwang Taiwan 11 182 1.1× 73 0.6× 142 1.4× 75 0.8× 86 1.1× 22 589
Solomon Genet Ethiopia 9 44 0.3× 45 0.4× 28 0.3× 87 0.9× 52 0.7× 27 464
Chi-Feng Liu Taiwan 16 126 0.8× 69 0.6× 110 1.0× 147 1.5× 124 1.7× 31 683
Samar Abdelhady Lebanon 8 98 0.6× 54 0.5× 34 0.3× 204 2.1× 39 0.5× 11 522

Countries citing papers authored by Thomas Friedemann

Since Specialization
Citations

This map shows the geographic impact of Thomas Friedemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Friedemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Friedemann more than expected).

Fields of papers citing papers by Thomas Friedemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Friedemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Friedemann. The network helps show where Thomas Friedemann may publish in the future.

Co-authorship network of co-authors of Thomas Friedemann

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Friedemann. A scholar is included among the top collaborators of Thomas Friedemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Friedemann. Thomas Friedemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yang, Thomas Friedemann, Fuxiang Wang, et al.. (2025). Shufeng Jiedu Granule against mild COVID-19: Protocol of the randomized, double-blind, placebo-controlled, multi-center heal-COVID phase III study. Chinese Herbal Medicines. 17(3). 601–608.
2.
Friedemann, Thomas, Yuelai Chen, Francesca Ambrosini, et al.. (2024). A randomized controlled study on acupuncture for peri‐operative pain after open radical prostatectomy. British Journal of Urology. 133(6). 725–732. 3 indexed citations
5.
Zhang, Cui, Yuan Zhou, Yong Li, et al.. (2022). Shufeng Jiedu capsule ameliorates olfactory dysfunction via the AMPK/mTOR autophagy pathway in a mouse model of allergic rhinitis. Phytomedicine. 107. 154426–154426. 3 indexed citations
6.
Yang, Li, Thomas Friedemann, & Jian Pan. (2021). Ecdysterone Attenuates the Development of Radiation-Induced Oral Mucositis in Rats at Early Stage. Radiation Research. 196(4). 366–374. 3 indexed citations
7.
Tao, Zhengang, Lei Zhang, Thomas Friedemann, et al.. (2020). Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia. Journal of Functional Foods. 75. 104243–104243. 18 indexed citations
9.
Xia, Lu, Jun Chen, Thomas Friedemann, et al.. (2020). The Course of Mild and Moderate COVID-19 Infections—The Unexpected Long-Lasting Challenge. Open Forum Infectious Diseases. 7(9). ofaa286–ofaa286. 16 indexed citations
11.
Schröder, Sven, Gesa Meyer‐Hamme, Thomas Friedemann, et al.. (2017). Immediate Pain Relief in Adhesive Capsulitis by Acupuncture—A Randomized Controlled Double-Blinded Study. Pain Medicine. 18(11). 2235–2247. 26 indexed citations
12.
Friedemann, Thomas, Weigang Wang, Edgar R. Kramer, et al.. (2016). Neuroprotective Effect ofCoptis chinensisin MPP+ and MPTP-Induced Parkinson’s Disease Models. The American Journal of Chinese Medicine. 44(5). 907–925. 35 indexed citations
13.
Friedemann, Thomas, Udo Schumacher, Tao Yi, Alexander Kai‐Man Leung, & Sven Schröder. (2015). Neuroprotective Activity of Coptisine fromCoptis chinensis(Franch). Evidence-based Complementary and Alternative Medicine. 2015. 1–9. 43 indexed citations
14.
Friedemann, Thomas, Benjamin Otto, Udo Schumacher, et al.. (2014). Coptis chinensis Franch. exhibits neuroprotective properties against oxidative stress in human neuroblastoma cells. Journal of Ethnopharmacology. 155(1). 607–615. 44 indexed citations
15.
Schröder, Sven, Giovanna Franconi, Gesa Meyer‐Hamme, et al.. (2013). Can Medical Herbs Stimulate Regeneration or Neuroprotection and Treat Neuropathic Pain in Chemotherapy-Induced Peripheral Neuropathy?. Evidence-based Complementary and Alternative Medicine. 2013. 1–18. 64 indexed citations
16.
Meyer‐Hamme, Gesa, et al.. (2013). An Acupuncture Research Protocol Developed from Historical Writings by Mathematical Reflections: A Rational Individualized Acupoint Selection Method for Immediate Pain Relief. Evidence-based Complementary and Alternative Medicine. 2013. 1–16. 13 indexed citations
17.
Zhang, Jianwei, et al.. (2012). Mathematical Reflections on Acupoint Combinations in the Traditional Meridian Systems. Evidence-based Complementary and Alternative Medicine. 2012. 1–10. 7 indexed citations
18.
Meyer‐Hamme, Gesa, et al.. (2012). Treatment of Chemotherapy Induced Peripheral Neuropathy: The Role of Medicinal Herbs. 3(1). 15–39. 1 indexed citations
19.
Friedemann, Thomas, Xueyong Shen, Jürgen Bereiter‐Hahn, & Wolfgang Schwarz. (2011). Regulation of the cardiovascular function by CO2 laser stimulation in anesthetized rats. Lasers in Medical Science. 27(2). 469–477. 12 indexed citations
20.
Friedemann, Thomas, Weimin Li, & Zhijun Wang. (2009). Inhibitory regulation of blood pressure by manual acupuncture in the anesthetized rat. Autonomic Neuroscience. 151(2). 178–182. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026